Vimeo
LinkedIn
Instagram
Share |

medtech

June 9, 2022

Companies developing complex disease-solving data curation, heart-failure telemonitoring and home sperm testing will exclusively present in-person as Campden Wealth returns to Lausanne, Switzerland, for the 32nd edition of the MedTech Investing Europe Forum (MTi) on July 12 and 13.

Companies developing complex disease-solving data curation, heart-failure telemonitoringand home sperm testing will exclusively present in-person as Campden Wealth returns to Lausanne, Switzerland, for the 32nd edition of the MedTech Investing Europe Forum (MTi) on July 12 and 13.

April 4, 2022

INSPIRA is developing a cost-effective respiratory support system which will function as an artificial lung for deteriorating respiratory patients. Ahead of presenting at the 32nd edition of the MedTech investing (MTi) forum on June 6 and 7, president and co-founder Joe Hayon explains the benefits and potential future applications of the system.

INSPIRA is an innovative medical device company which is developing the ART system, a cost-effective early extracorporeal respiratory support system which will function as an artificial lung for deteriorating respiratory patients.

The ART system utilises a new approach based on hemo-protective technology aimed at rebalancing oxygen saturation levels while patients are awake and breathing, potentially minimising the patient's need for invasive mechanical ventilation intervention.

March 31, 2022

Medtech company Edinburgh Biosciences (EBS) is working towards a global solution for the diagnosis and treatment of cataracts. Ahead of presenting at the 32nd edition of the MedTech investing (MTi) forum, chief executive officer Dr Graham Bell, explains the benefits and potential future applications of the technology.

Medtech company Edinburgh Biosciences (EBS) is working towards a global solution for the diagnosis and treatment of cataracts. Using a new light-based non-surgical treatment, this cutting-edge treatment has already proved effective in clinical trials.

Ahead of presenting at the 32nd edition of the MedTech investing (MTi) forum on June 6 and 7, Edinburgh Biosciences’ chief executive officer Dr Graham Bell, explains the benefits and potential future applications of the technology.

February 16, 2022

For nearly three decades, Dr. Werner Tschollar has been at the forefront of the pharmaceutical, biotech and financing industries. With a humanitarian approach to life and a savvy head for business, he has parlayed his extensive credentials and experience into a series of innovative products and treatments that have changed the quality of life for countless people.

For nearly three decades, Dr. Werner Tschollar has been at the forefront of the pharmaceutical, biotech and financing industries. With a humanitarian approach to life and a savvy head for business, he has parlayed his extensive credentials and experience into a series of innovative products and treatments that have changed the quality of life for countless people.

September 30, 2021

Deep tech is much talked about by governments, and the European Commission especially, but often without an explanation of what it actually is. Only by defining, and therefore assessing, its character can we consider its place in the European startup ecosystem.

Deep tech is much talked about by governments, and the European Commission especially, but often without an explanation of what it actually is. Only by defining, and therefore assessing, its character can we consider its place in the European startup ecosystem.

Stephen Nundy, partner at Lakestar, and Yoram Wijngaarde, founder and chief executive of Dealroom, in conversation about the future of deep tech and its role in Europe’s future.

September 22, 2021

The European Union’s regulation of medical devices in Europe only began in the 1990s. Previously, member states acted independently, but the differing national requirements were replaced by EU directives including the 1993 Medical Devices Directive (MDD) and the 1998 In Vitro Diagnostics Directive (IVDD). 

The European Union’s regulation of medical devices in Europe only began in the 1990s. Previously, member states acted independently, but the differing national requirements were replaced by EU directives including the 1993 Medical Devices Directive (MDD) and the 1998 In Vitro Diagnostics Directive (IVDD).

September 14, 2021

The chairman of Supernova Invest, the pioneer and leader of deep tech investment in France, will discuss how investors, families and companies can achieve their goals at the in-person MedTech Investing Europe Forum.

The chairman of Supernova Invest, the pioneer and leader of deep tech investment in France, will discuss how investors, families and companies can achieve their goals at the in-person MedTech Investing Europe Forum.

August 16, 2021

For an innovative investment to pay off, the pieces of the research and development puzzle need to fall into place perfectly—especially in life sciences and MedTech.

For an innovative investment to pay off, the pieces of the research and development puzzle need to fall into place perfectly—especially in life sciences and MedTech.

In Flanders, the northern region of Belgium, you’ll find all the required ingredients: companies that adapt quickly and work together, academic institutions and research centres that support the ambitions of entrepreneurs, government agencies that think with and support the world of business in a hands-on way. It’s all available in a compact and dense knowledge network.

July 27, 2021

Say Flanders, think research and technology. Belgium’s northern region is a well-known beacon of innovation. Its companies, research centres and knowledge institutions are at the basis of ground-breaking solutions in niches like digital, health and climate tech.

Say Flanders, think research and technology. Belgium’s northern region is a well-known beacon of innovation. Its companies, research centres and knowledge institutions are at the basis of ground-breaking solutions in niches like digital, health and climate tech.

Through its worldwide Science and Technology Offices, Flanders Investment and Trade helps Flanders build bridges of knowhow and innovative strength across the globe—and you can reap the rewards, too.

Click here >>
Close